PYRUKYND 20mg+50mg film-coated tablets AGIOS NETHERLANDS B.
mitapivat Indicated for: pyruvate kinase deficiency
B06AX04 Blood and blood forming organs | Other hematological agents | Other hematological agents
letter P · page 72
mitapivat Indicated for: pyruvate kinase deficiency
B06AX04 Blood and blood forming organs | Other hematological agents | Other hematological agents
mitapivat Indicated for: pyruvate kinase deficiency
B06AX04 Blood and blood forming organs | Other hematological agents | Other hematological agents
mitapivat Indicated for: pyruvate kinase deficiency
B06AX04 Blood and blood forming organs | Other hematological agents | Other hematological agents
mitapivat Indicated for: pyruvate kinase deficiency
B06AX04 Blood and blood forming organs | Other hematological agents | Other hematological agents
ustekinumab Indicated for: autoimmune inflammatory diseases
ustekinumab Indicated for: autoimmune inflammatory diseases
ustekinumab Indicated for: autoimmune inflammatory diseases
ustekinumab Indicated for: autoimmune inflammatory diseases
ustekinumab Indicated for: autoimmune inflammatory diseases
pazopanib Indicated for: cancer
pazopanib Indicated for: cancer